| Q37759654 | A review of the effects of vitamins and other dietary supplements on seizure activity |
| Q40142216 | Anticonvulsant drugs. An update |
| Q40780187 | Antiepileptic drugs. A review of clinically significant drug interactions. |
| Q69329726 | Cerebrospinal folate levels in epileptics and their response to folate therapy |
| Q36522161 | Chronic Antiepileptic Toxicity: A Review |
| Q37920931 | Clinically relevant anti-epileptic drug interactions |
| Q40266493 | Controlled trials in epilepsy: a review |
| Q44732130 | Down syndrome and epilepsy: a nutritional connection? |
| Q38549352 | Drug and environmental factors associated with adverse pregnancy outcomes. Part III: Folic acid: pharmacology, therapeutic recommendations, and economics |
| Q40300215 | Drug interactions with phenytoin |
| Q39812212 | Drugs and Vitamin Deficiency |
| Q39827393 | Drugs and folate metabolism |
| Q28571769 | Effect of chronic valproate treatment on folate-dependent methyl biosynthesis in the rat |
| Q33855249 | Elevated plasma concentrations of homocysteine in antiepileptic drug treatment |
| Q48442456 | Epileptogenic properties of folic acid and N5 methyltetrahydrofolate in cat |
| Q52114831 | Folate deficiency in psychiatric practice |
| Q48598041 | Folic acid deficiency and epilepsy |
| Q57317338 | Folic acid fortification of grain: an economic analysis |
| Q72557234 | Folic acid improves phenytoin pharmacokinetics |
| Q28337260 | Harmful effect of megadoses of vitamins: electroencephalogram abnormalities and seizures induced by intravenous folate in drug-treated epileptics |
| Q48763970 | Interaction of phenytoin and folate in the rat. |
| Q39813650 | Interactions Between Drugs and Nutrients |
| Q42465478 | Kearns-Sayre syndrome with reduced plasma and cerebrospinal fluid folate |
| Q51215755 | Mental deterioration in epilepsy. |
| Q48291648 | Modulation of potassium evoked secretory function in rat cerebellar slices measured by real time monitoring: evidence of a possible role for methylfolate in cerebral tissue |
| Q37909318 | Pharmacokinetic drug interactions with phenytoin (Part II). |
| Q40329711 | Pharmacokinetic interactions with antiepileptic drugs |
| Q33574412 | Phenytoin, folic acid and gingival enlargement: Breaking myths |
| Q40921749 | Phenytoin-folic acid interaction |
| Q52094599 | Psychological disturbances and folic acid in chronic epileptic outpatients. |
| Q34082050 | Quality-of-life and behavioral outcome measures in randomized controlled trials of antiepileptic drugs: a systematic review of methodology and reporting standards |
| Q46390092 | Teratogenicity of antiepileptic drugs |
| Q42934693 | The clinical consequences of chronic hepatic enzyme induction by anticonvulsant drugs |
| Q71012531 | The inability of oral leucovorin to elevate CSF 5-methyl-tetrahydrofolate following high dose intravenous methotrexate therapy |
| Q72872715 | The role of folate deficiency in the development of peripheral neuropathy caused by anticonvulsants |
| Q77764410 | Treatment of concomitant illnesses in patients receiving anticonvulsants: drug interactions of clinical significance |
| Q24246947 | Vitamins for epilepsy |
| Q71231708 | [Serum folic acid in anticonvulsant long term therapy (author's transl)] |